ENElsa Nico

Elsa Nico

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elsa Nico has a total of 85 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Malignant Melanoma Presenting as a Cavernous Malformation: Systematic Literature Review and Report of 4 Illustrative Cases

    by Elsa Nico, Nicole K. Nikolov, Satvir Saggi, Ashia M. Hackett, Stefan W. Koester, Adam T. Eberle, Joelle N. Hartke, Samuel L. Malnik, Brandon M. Fox, Ethan A. Winkler, et al.

  • Open Access

    Vision Outcomes Following Endoscopic and Microscopic Transsphenoidal Resection of Sellar/Parasellar Lesions – A Systematic Review of the Literature

    by Emal Lesha, John E. Dugan, Camille Milton, Elsa Nico, Logan Eskin, Kaan Yagmurlu, Emir Begagic, Mirza Pojskic, Kenan Arnautovic

  • Open Access

    Outcomes of Microsurgical Treatment for Unruptured Intracranial Aneurysms: A 7-Year Institutional Review

    by Joshua S. Catapano, Stefan W. Koester, Margaret M. McCann, Emmajane G. Rhodenhiser, Lea Scherschinski, Adam T. Eberle, Kate N. Jensen, Anant Naik, Ashia M. Hackett, Elsa Nico, et al.

    BACKGROUND AND OBJECTIVES: The optimal management of unruptured intracranial aneurysms (UIAs) remains controversial. Options include observation, endovascular treatment, microsurgical intervention, or a combination. However, clear outcome data for UIA treatment remain elusive. This study analyzed UIA treatment outcomes at a quaternary center and explored factors associated with poor neurological outcomes. METHODS: All records of patients treated for UIA from 2014 through 2020 were retrospectively reviewed. Inclusion criteria were availability of treatment data, adequate follow-up, and a modified Rankin Scale (mRS) score of ≤2 at admission. Outcomes analyzed included 1-year mRS scores, with a poor neurological outcome defined as an mRS score of >2. Multivariate logistic regression analysis included variables with P < .2 on univariate analysis. RESULTS: A total of 390 patients met the inclusion criteria (294 [75.4%] women, 96 [24.6%] men). Forty-one (10.5%) had previous aneurysmal subarachnoid hemorrhages (SAHs). The mean (SD) population, hypertension, age, size of aneurysm, earlier SAH from another aneurysm, site of aneurysm (PHASES) score was 4.5 (2.7). Thirty-eight patients (9.7%) had mRS scores >2 at the 1-year follow-up. Of 555 UIAs, 388 (69.9%) were saccular and 77 (13.9%) were in the posterior circulation. Multivariate analysis showed that no tobacco use (odds ratio [OR] 4.35, 95% CI: 1.72-12.5, P = .003), diabetes mellitus (OR 3.09, 95% CI: 1.00-9.29, P = .045), hyperlipidemia (OR 4.33, 95% CI: 1.33-14.0, P = .01), and PHASES score ≥6 (OR 3.92, 95% CI: 1.30-12.7, P = .02) were predictors of poor neurological outcome at the 1-year follow-up. Of the 555 UIAs treated, 1 (0.2%) required retreatment and 12 (2.5%) residual aneurysms were noted on follow-up, with no aneurysmal SAH post-treatment. CONCLUSION: Microsurgical treatment of UIAs is associated with low rates of residual aneurysms, retreatment, and poor neurological outcomes. Risk factors for a poor neurological outcome included no history of tobacco use, presence of diabetes mellitus, hyperlipidemia, and a high PHASES score. These findings refute the potential value of treating patients with low PHASES scores.

  • Open Access

    Predictors of Outcome Clusters in Patients With Unruptured Intracranial Aneurysms Treated With Microsurgery: An Unsupervised Machine Learning Analysis

    by Stefan W. Koester, Olga Ciobanu-Caraus, Anant Naik, Emmajane G. Rhodenhiser, Lea Scherschinski, Adam T. Eberle, Joelle N. Hartke, Elsa Nico, Ashia M. Hackett, Visish M. Srinivasan, et al.

    BACKGROUND AND OBJECTIVES: Identifying surgical candidates who are prone to poor outcomes is crucial for adapting treatment and ensuring optimal outcomes. Our aim was to use unsupervised machine learning to reveal patient outcome subgroups and identify predictors of attribution to these subgroups in patients with unruptured intracranial aneurysms. METHODS: We retrospectively reviewed 400 patients who underwent microsurgical treatment for unruptured aneurysms at a large quaternary center from January 1, 2014, to December 31, 2020. Evaluated outcomes included new neurological deficits at discharge and poor neurological outcome at follow-up. Outcomes were clustered using a k-means model after the number of optimal clusters was obtained using a total within sum of squares algorithm. Uniform manifold approximation and projection was used to project the outcomes into a 2-dimensional space. On cluster determination, multivariate regression with a P -inclusion of ≤.20 was used. RESULTS: Three unique clusters were identified. Cluster 1 represented patients who had no poor neurological outcome (0/142, 0%) and no neurological deficits at discharge (0%). Cluster 2 represented patients with a high burden of new neurological deficit at discharge (76/143 [53%]) but no poor neurological outcome (0%). Cluster 3 represented patients with a new neurological deficit at discharge (52/115 [45%], P < .001) and a poor neurological outcome (47/115 [41%], P < .001). The mean (SD) population, hypertension, age, size of aneurysm, earlier subarachnoid hemorrhage from another aneurysm, site of aneurysm score was highest in cluster 3 vs cluster 2 vs cluster 1 (5.03 [2.83] vs 4.71 [2.56] vs 3.91 [2.66], P < .001). On multivariate analysis, diabetes and hyperlipidemia significantly predicted nonmembership in cluster 1. CONCLUSION: Unsupervised machine learning grouped outcomes into 3 distinct, clinically meaningful clusters. Vascular comorbidities, rather than aneurysm characteristics, significantly predicted attribution to outcome clusters.


  • Open Access

    Posterior Inferior Cerebellar Artery Double Reimplantation Bypass for Treatment of a Dolichoectatic Posterior Inferior Cerebellar Artery Aneurysm: A Technical Report

    by Ashia M. Hackett, Christopher O. Adereti, Elsa Nico, Lea Scherschinski, Matthew L. Pace, Adam T. Eberle, Samuel L. Malnik, Joelle N. Hartke, Brandon M. Fox, Ethan A. Winkler, et al.

    BACKGROUND AND IMPORTANCE: The surgical management of posterior inferior cerebellar artery (PICA) aneurysms often poses a challenge because of tight surgical corridors, proximity to the lower cranial nerves, and the presence of perforators supplying the medulla. This report describes an excision and double reimplantation bypass for treatment of a dolichoectatic PICA aneurysm found on familial screening in a young man with a family history of aneurysmal subarachnoid hemorrhage. CLINICAL PRESENTATION: The patient underwent a right far-lateral craniotomy with excision of the dolichoectatic right PICA aneurysm with an additional outflow branch. An end-to-end reanastomosis was performed from the proximal PICA to the larger distal outflow PICA vessel, followed by an end-to-side anastomosis of the second outflow branch to the distal PICA; a salvage bypass with side-to-side V4-p2 reimplantation was later conducted because of thrombus formation at the initial end-to-end reanastomosis. CONCLUSION: PICA aneurysms are uncommon and difficult to treat because of their location and complex anatomy, often requiring unique bypass techniques. This case was further complicated by a thrombus formation, which was likely caused by pathological aneurysmal tissue being incorporated in the bypass. This case required an unconventional bypass construct that proved to be effective.

  • Prognostic Factors in Idiopathic Normal Pressure Hydrocephalus Patients After Ventriculo-Peritoneal Shunt: Results from a Single-Institution Observational Cohort Study with Long Term Follow-Up

    by Andrea Bianconi, Stefano Colonna, Massimiliano Minardi, Giuseppe Di Perna, Luca Ceroni, Elsa Nico, Diego Garbossa, Silvana Borgarello, Fabio Cofano


  • Open Access

    Assessing the Relationship between Surgical Timing and Postoperative Seizure Outcomes in Cavernoma-Related Epilepsy: A Single-Institution Retrospective Analysis of 63 Patients with a Review of the Literature

    by Elsa Nico, Christopher O. Adereti, Ashia M. Hackett, Andrea Bianconi, Anant Naik, Adam T. Eberle, Pere J. Cifre Serra, Stefan W. Koester, Samuel L. Malnik, Brandon M. Fox, et al.

    Background: Patients with supratentorial cavernous malformations (SCMs) commonly present with seizures. First-line treatments for cavernoma-related epilepsy (CRE) include conservative management (antiepileptic drugs (AEDs)) and surgery. We compared seizure outcomes of CRE patients after early (≤6 months) vs. delayed (>6 months) surgery. Methods: We compared outcomes of CRE patients with SCMs surgically treated at our large-volume cerebrovascular center (1 January 2010–31 July 2020). Patients with 1 sporadic SCM and ≥1-year follow-up were included. Primary outcomes were International League Against Epilepsy (ILAE) class 1 seizure freedom and AED independence. Results: Of 63 CRE patients (26 women, 37 men; mean ± SD age, 36.1 ± 14.6 years), 48 (76%) vs. 15 (24%) underwent early (mean ± SD, 2.1 ± 1.7 months) vs. delayed (mean ± SD, 6.2 ± 7.1 years) surgery. Most (32 (67%)) with early surgery presented after 1 seizure; all with delayed surgery had ≥2 seizures. Seven (47%) with delayed surgery had drug-resistant epilepsy. At follow-up (mean ± SD, 5.4 ± 3.3 years), CRE patients with early surgery were more likely to have ILAE class 1 seizure freedom and AED independence than those with delayed surgery (92% (44/48) vs. 53% (8/15), p = 0.002; and 65% (31/48) vs. 33% (5/15), p = 0.03, respectively). Conclusions: Early CRE surgery demonstrated better seizure outcomes than delayed surgery. Multicenter prospective studies are needed to validate these findings.


  • Open Access

    Racial and Socioeconomic Status among a Patient Population Presenting with Aneurysmal Subarachnoid Hemorrhage versus Unruptured Intracranial Aneurysm: A Single-Center Study

    by Ashia M. Hackett, Christopher O. Adereti, Ariel P. Walker, Elsa Nico, Lea Scherschinski, Emmajane G. Rhodenhiser, Adam T. Eberle, Anant Naik, Juan P. Giraldo, Joelle N. Hartke, et al.

    Racial and socioeconomic health disparities are well documented in the literature. This study examined patient demographics, including socioeconomic status (SES), among individuals presenting with aneurysmal subarachnoid hemorrhage (aSAH) and unruptured intracranial aneurysm (UIA) to identify factors associated with aSAH presentation. A retrospective assessment was conducted of all patients with aSAH and UIA who presented to a large-volume cerebrovascular center and underwent microsurgical treatment from January 2014 through July 2019. Race and ethnicity, insurance type, and SES data were collected for each patient. Comparative analysis of the aSAH and UIA groups was conducted. Logistic regression models were also employed to predict the likelihood of aSAH presentation based on demographic and socioeconomic factors. A total of 640 patients were included (aSAH group, 251; UIA group, 389). Significant associations were observed between race and ethnicity, SES, insurance type, and aneurysm rupture. Non-White race or ethnicity, lower SES, and having public or no insurance were associated with increased odds of aSAH presentation. The aSAH group had poorer functional outcomes and higher mortality rates than the UIA group. Patients who are non-White, have low SES, and have public or no insurance were disproportionately affected by aSAH, which is historically associated with poorer functional outcomes.


  • Optimal PHASES Scoring for Risk Stratification of Surgically Treated Unruptured Aneurysms

    by Stefan W. Koester, Emmajane G. Rhodenhiser, Stephen J. Dabrowski, Lea Scherschinski, Joelle N. Hartke, Anant Naik, Katherine Karahalios, Elsa Nico, Ashia M. Hackett, Olga Ciobanu-Caraus, et al.


  • Open Access

    Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy

    by Andrea Bianconi, Emanuele Koumantakis, Andrea Gatto, Pietro Zeppa, Ayoub Saaid, Elsa Nico, Francesco Bruno, Alessia Pellerino, Francesca Rizzo, Carola Vera Junemann, et al.